Crossject - Product Pipeline Analysis, 2014 Update

Date: May 14, 2014
Pages: 19
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C733F48F809EN
Leaflet:

Download PDF Leaflet

Crossject - Product Pipeline Analysis, 2014 Update
Summary

Crossject is a medical device company. It manufactures and markets needleless drug self- injections. The company by using its needle-free injection system, ZENEO, develops a pipeline of high value SUPERGENERICS. Crossject’s ZENEO is an advanced disposable, pre-filled, needle-free, automatic injection system. ZENO can deliver can deliver drugs intradermally, subcutaneously and intramuscularly. Crossject’s pipeline portfolio includes methotrexate for rheumatoid arthritis; epinephrine for anaphylactic shock; and sumatriptan for acute migraine. It partners with bertin, hirtenberger, SCHOTT, and RECIPHARM. The company is an ISO: 13485 certified. Crossject is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Crossject
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Crossject Company Snapshot
Crossject Company Overview
Key Information
Crossject Pipeline Products and Clinical Trials Overview
Crossject – Pipeline Analysis Overview
Key Facts
Crossject - Major Products and Services
Crossject Pipeline Products by Development Stage
Crossject Pipeline Products Overview
Zeneo ID Human Needle-Free Injection Device
Zeneo ID Human Needle-Free Injection Device Product Overview
Zeneo IM 0.5ml Needle-Free Injection Device
Zeneo IM 0.5ml Needle-Free Injection Device Product Overview
Zeneo SC 0.5ml Needle-Free Injection Device
Zeneo SC 0.5ml Needle-Free Injection Device Product Overview
Zeneo SC 0.8ml Needle-Free Injection Device
Zeneo SC 0.8ml Needle-Free Injection Device Product Overview
Zeneo SC High Viscosity Needle-Free Injection Device
Zeneo SC High Viscosity Needle-Free Injection Device Product Overview
Crossject - Key Competitors
Crossject - Key Employees
Crossject - Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Crossject, Key Facts
Crossject Pipeline Products and Clinical Trials Overview
Crossject Pipeline Products by Equipment Type
Crossject, Key Facts
Crossject, Major Products and Services
Crossject Number of Pipeline Products by Development Stage
Crossject Pipeline Products Summary by Development Stage
Zeneo ID Human Needle-Free Injection Device - Product Status
Zeneo ID Human Needle-Free Injection Device - Product Description
Zeneo IM 0.5ml Needle-Free Injection Device - Product Status
Zeneo IM 0.5ml Needle-Free Injection Device - Product Description
Zeneo SC 0.5ml Needle-Free Injection Device - Product Status
Zeneo SC 0.5ml Needle-Free Injection Device - Product Description
Zeneo SC 0.8ml Needle-Free Injection Device - Product Status
Zeneo SC 0.8ml Needle-Free Injection Device - Product Description
Zeneo SC High Viscosity Needle-Free Injection Device - Product Status
Zeneo SC High Viscosity Needle-Free Injection Device - Product Description
Crossject, Key Employees

LIST OF FIGURES

Crossject Pipeline Products by Equipment Type
Crossject Pipeline Products by Development Stage
Skip to top


Ask Your Question

Crossject - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: